XML 24 R10.htm IDEA: XBRL DOCUMENT
v3.25.3

Composition of Certain Consolidated Financial Statement Line Items | 9 Months Ended
--- | ---
Sep. 30, 2025
Composition of Certain Consolidated Financial Statement Line Items |
Composition of Certain Consolidated Financial Statement Line Items | 3. Composition of Certain Consolidated Financial Statement Line Items Accrued expenses and other current liabilities consisted of the following (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | SEPTEMBER 30, | ​ | DECEMBER 31, | ​
​ |  | 2025 |  | 2024 |
Accrued compensation | ​ | $ | 8,551 | ​ | $ | 7,290 | ​
Accrued research and development expenses | ​ |  | 5,192 | ​ |  | 5,460 | ​
Accrued clinical expenses | ​ | ​ | 13,493 | ​ | ​ | 7,025 | ​
Accrued professional services | ​ | ​ | 3,122 | ​ | ​ | 2,918 | ​
Accrued other liabilities | ​ |  | 6,571 | ​ |  | 3,606 | ​
Total accrued expenses and other current liabilities | ​ | $ | 36,929 | ​ | $ | 26,299 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​

X
- References No definition available. + Details
Name: | srt_ItemsIncludedInConsolidatedStatementOfFinancialConditionAbstract
Namespace Prefix: | srt_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/210/tableOfContent + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration